SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-524725
Filing Date
2016-03-31
Accepted
2016-03-31 07:32:03
Documents
14
Period of Report
2016-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d212643d8k.htm 8-K 13090
2 EX-99.1 d212643dex991.htm EX-99.1 61535
3 GRAPHIC g212643ex99_1s10gbgd.jpg GRAPHIC 65071
4 GRAPHIC g212643ex99_1s11gbgd.jpg GRAPHIC 20289
5 GRAPHIC g212643ex99_1s12gbgd.jpg GRAPHIC 22771
6 GRAPHIC g212643ex99_1s1gbgd.jpg GRAPHIC 28417
7 GRAPHIC g212643ex99_1s2gbgd.jpg GRAPHIC 20521
8 GRAPHIC g212643ex99_1s3gbgd.jpg GRAPHIC 33130
9 GRAPHIC g212643ex99_1s4gbgd.jpg GRAPHIC 35361
10 GRAPHIC g212643ex99_1s5gbgd.jpg GRAPHIC 52773
11 GRAPHIC g212643ex99_1s6gbgd.jpg GRAPHIC 32609
12 GRAPHIC g212643ex99_1s7gbgd.jpg GRAPHIC 43379
13 GRAPHIC g212643ex99_1s8gbgd.jpg GRAPHIC 40284
14 GRAPHIC g212643ex99_1s9gbgd.jpg GRAPHIC 35745
  Complete submission text file 0001193125-16-524725.txt   670072
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 161541637
SIC: 2834 Pharmaceutical Preparations